FIELD: medicine.
SUBSTANCE: invention relates to biotechnology. Described is immunotherapeutic or preventive vaccine, applied in/against viral infectious disease or cancer, which contains pharmaceutically efficient number of B-cells, selected from group, consisting of B-cells, obtained by loading them with ligand of T-cells-natural killers and sensibilising antigen, and B-cells, obtained by loading them with ligand of T-cells-natural killers and transfer of gene, coding peptide antigen or protein antigen, by which B-cells express antigen, and pharmaceutically acceptable carrier. Claimed is method of inducing cytotoxic response in patient, who needs treatment, which includes introduction of described vaccine to patient.
EFFECT: invention extends arsenal of means of immunotherapy or prevention of viral infectious disease, bacterial infectious disease or cancer.
11 cl, 24 dwg, 12 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMBINATION PREPARATION FOR INCREASING POTENCY OF VACCINE (VERSIONS) | 2008 |
|
RU2491090C2 |
| COMPOSITIONS AND METHODS FOR ENHANCING IMMUNE RESPONSE TO ANTIGENS | 2008 |
|
RU2537188C2 |
| COMPOSITION FOR STIMULATING DENDRITIC CELL MATURATION, CONTAINING HYBRID PROTEIN RV2299C/ESAT-6 | 2017 |
|
RU2733886C2 |
| POLYEPITOPE IMMUNOGENIC POLYPEPTIDES AND METHODS OF APPLICATION THEREOF | 2013 |
|
RU2598265C2 |
| INTRACELLULAR DOMAIN OF PROTEIN HER-2/NEU FOR PROPHYLAXIS AND TREATMENT OF MALIGNANCY | 1996 |
|
RU2236461C2 |
| CDH3-PEPTIDE AND DRUG PREPARATION CONTAINING IT | 2008 |
|
RU2483078C2 |
| METHOD OF PRODUCING ANTIGEN-SPECIFIC CYTOTOXIC CELLS HAVING ACTIVITY AGAINST BREAST CANCER CELLS | 2013 |
|
RU2596920C2 |
| POLYEPITOPE ANTI-TUMOUR VACCINE STRUCTURE CONTAINING EPITOPES OF TUMOR-ASSOCIATED ANTIGENS, PHARMACEUTICAL COMPOSITION AND ITS APPLICATION FOR STIMULATING SPECIFIC ANTI-TUMOR IMMUNE RESPONSE | 2016 |
|
RU2684235C2 |
| METHOD FOR ACTIVATING CYTOTOXIC T-LYMPHOCYTES IN A POPULATION OF BLOOD MONONUCLEAR CELLS USING MEMBRANE VESICLES OBTAINED FROM GENETICALLY MODIFIED TUMOR CELLS OF M14 MELANOMA WITH OVEREXPRESSION OF INTERLEUKIN 2 | 2022 |
|
RU2790867C1 |
| METHOD FOR IMMUNE THERAPY OF CHRONIC VIRAL HEPATITIS C | 2016 |
|
RU2637631C2 |
